3,4,5-Trimethoxy-trans-cinnamic acid manufacturers
|
| | 3,4,5-Trimethoxy-trans-cinnamic acid Basic information |
| Product Name: | 3,4,5-Trimethoxy-trans-cinnamic acid | | Synonyms: | (E)-3-(3,4,5-TRIMETHOXY-PHENYL)-ACRYLIC ACID;AKOS BBS-00000775;3-(3,4,5-TRIMETHOXYPHENYL)ACRYLIC ACID;(E)-3-(3,4,5-Trimethoxyphenyl)propenoic acid;3,4,5-Trimethoxycinnamic acid;OTAVA-BB BB7119152925;RARECHEM BK HC T328;trans-3,4,5-TriMethoxycinnaMic acid | | CAS: | 20329-98-0 | | MF: | C12H14O5 | | MW: | 238.24 | | EINECS: | 201-999-8 | | Product Categories: | | | Mol File: | 20329-98-0.mol |  |
| | 3,4,5-Trimethoxy-trans-cinnamic acid Chemical Properties |
| Melting point | 125-127 °C(lit.) | | Boiling point | 396.4±37.0 °C(Predicted) | | density | 1.209±0.06 g/cm3(Predicted) | | storage temp. | Sealed in dry,Room Temperature | | pka | 4.48±0.10(Predicted) | | form | powder to crystal | | color | White to Light yellow | | InChI | InChI=1S/C12H14O5/c1-15-9-6-8(4-5-11(13)14)7-10(16-2)12(9)17-3/h4-7H,1-3H3,(H,13,14)/b5-4+ | | InChIKey | YTFVRYKNXDADBI-SNAWJCMRSA-N | | SMILES | C(O)(=O)/C=C/C1=CC(OC)=C(OC)C(OC)=C1 |
| Safety Statements | 24/25 | | WGK Germany | 2 | | RTECS | GE0722000 | | HS Code | 2918.99.4700 |
| | 3,4,5-Trimethoxy-trans-cinnamic acid Usage And Synthesis |
| Uses | (E)-3,4,5-Trimethoxycinnamic acid (TMCA) is a cinnamic acid substituted by multi-methoxy groups. (E)-3,4,5-Trimethoxycinnamic acid is an orally active and potent GABAA/BZ receptor agonist. (E)-3,4,5-Trimethoxycinnamic exhibits favourable binding affinity to 5-HT2C and 5-HT1A receptor, with IC50 values of 2.5 and 7.6 μM, respectively. (E)-3,4,5-Trimethoxycinnamic acid shows anticonvulsant and sedative activity. (E)-3,4,5-Trimethoxycinnamic acid can be used for the research of insomnia, headache and epilepsy[1][2][3]. | | Definition | ChEBI: 3,4,5-trimethoxycinnamic acid is a methoxycinnamic acid with three methoxy substituents at the 3-, 4- and 5-positions. It has a role as an allergen. It is a conjugate acid of a 3,4,5-trimethoxycinnamate. | | in vivo | (E)-3,4,5-Trimethoxycinnamic acid (0-20 mg/kg, IP, once) shows anti-seizure effects[2].
(E)-3,4,5-Trimethoxycinnamic acid (0-10 mg/kg, Orally, once) enhances hypnotic effects in pentobarbital-treated mice[3]. | Animal Model: | Ault male KunMing-strain mice (18-20 g, maximal electroshock (MES) and pentylenetetrazol (PTZ) models)[2] | | Dosage: | 5, 10 and 20 mg/kg; 10 mL/kg | | Administration: | IP, once | | Result: | Significantly decreased the incidence of MES-induced THE (tonic hindlimb extension) to 50% and 20% of the value of the vehicle controls at 10 and 20 mg/kg. Decreased the incidence of MES-induced THE to only 80% at 5 mg/kg. Significantly delayed the onset of myoclonic jerks (MJ), and decreased the seizure severity and mortality compared with the vehicle-treated animals in PTZ seizure model. The incidence of generalized clonic convulsions (stage 4) disappeared at doses of both 10 and 20 mg/kg. |
| Animal Model: | ICR male mice (25-28 g, 10-12 in each group)[3] | | Dosage: | 2, 5 and 10 mg/kg | | Administration: | Orally (p.o.), once, 15 min and 1 h prior to pentobarbital injection | | Result: | Significantly decreased locomotor activity at 10 mg/kg. Increased NREM and total sleep, but decreased wakefulness. |
| | IC 50 | 5-HT1A Receptor: 7.6 μM (IC50); 5-HT2C Receptor: 2.5 μM (IC50); 5-HT2A Receptor: >10 μM (IC50); 5-HT6 Receptor: >10 μM (IC50); 5-HT7 Receptor: >10 μM (IC50) | | References | [1] Zhao Z, et al. Research progress in the biological activities of 3,4,5-trimethoxycinnamic acid (TMCA) derivatives. Eur J Med Chem. 2019 Jul 1;173:213-227. DOI:10.1016/j.ejmech.2019.04.009
[2] Chen CY, et al. 3,4,5-Trimethoxycinnamic acid, one of the constituents of Polygalae Radix exerts anti-seizure effects by modulating GABAAergic systems in mice. J Pharmacol Sci. 2016 May;131(1):1-5. DOI:10.1016/j.jphs.2015.07.021
[3] Lee CI, et al. 3,4,5-Trimethoxycinnamic acid (TMCA), one of the constituents of Polygalae Radix enhances pentobarbital-induced sleeping behaviors via GABAAergic systems in mice. Arch Pharm Res. 2013 Oct;36(10):1244-51. DOI:10.1007/s12272-013-0167-6 |
| | 3,4,5-Trimethoxy-trans-cinnamic acid Preparation Products And Raw materials |
|